Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David P. Siderovski is active.

Publication


Featured researches published by David P. Siderovski.


Nature | 1999

Molecular characterization of mitochondrial apoptosis-inducing factor

Santos A. Susin; Hans K. Lorenzo; Naoufal Zamzami; Isabel Marzo; Bryan E. Snow; Joan Mangion; Etienne Jacotot; Paola Costantini; Markus Loeffler; Nathanael Larochette; David R. Goodlett; Ruedi Aebersold; David P. Siderovski; Josef M. Penninger; Guido Kroemer

Mitochondria play a key part in the regulation of apoptosis (cell death). Their intermembrane space contains several proteins that are liberated through the outer membrane in order to participate in the degradation phase of apoptosis. Here we report the identification and cloning of an apoptosis-inducing factor, AIF, which is sufficient to induce apoptosis of isolated nuclei. AIF is a flavoprotein of relative molecular mass 57,000 which shares homology with the bacterial oxidoreductases; it is normally confined to mitochondria but translocates to the nucleus when apoptosis is induced. Recombinant AIF causes chromatin condensation in isolated nuclei and large-scale fragmentation of DNA. It induces purified mitochondria to release the apoptogenic proteins cytochrome c and caspase-9. Microinjection of AIF into the cytoplasm of intact cells induces condensation of chromatin, dissipation of the mitochondrial transmembrane potential, and exposure of phosphatidylserine in the plasma membrane. None of these effects is prevented by the wide-ranging caspase inhibitor known as Z-VAD.fmk. Overexpression of Bcl-2, which controls the opening of mitochondrial permeability transition pores, prevents the release of AIF from the mitochondrion but does not affect its apoptogenic activity. These results indicate that AIF is a mitochondrial effector of apoptotic cell death.


Cell | 1998

Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN

Vuk Stambolic; Akira Suzuki; José Luis de la Pompa; Christine Mirtsos; Takehiko Sasaki; Jürgen Ruland; Josef M. Penninger; David P. Siderovski; Tak W. Mak

PTEN is a tumor suppressor with sequence homology to protein tyrosine phosphatases and the cytoskeletal protein tensin. mPTEN-mutant mouse embryos display regions of increased proliferation. In contrast, mPTEN-deficient immortalized mouse embryonic fibroblasts exhibit decreased sensitivity to cell death in response to a number of apoptotic stimuli, accompanied by constitutively elevated activity and phosphorylation of protein kinase B/Akt, a crucial regulator of cell survival. Expression of exogenous PTEN in mutant cells restores both their sensitivity to agonist-induced apoptosis and normal pattern of PKB/Akt phosphorylation. Furthermore, PTEN negatively regulates intracellular levels of phosphatidylinositol (3,4,5) trisphosphate in cells and dephosphorylates it in vitro. Our results show that PTEN may exert its role as a tumor suppressor by negatively regulating the PI3K/PKB/Akt signaling pathway.


Current Biology | 1996

A new family of regulators of G-protein-coupled receptors?

David P. Siderovski; Andrew Hessel; Stephen Chung; Tak W. Mak; Mike Tyers

Organisms as diverse as fungi and humans use G-protein-coupled receptors to control signal transduction pathways responsive to various hormones, neuroregulatory molecules and other sensory stimuli. Continual stimulation of these receptors often leads to their desensitization, which is mediated in part by the consecutive actions of two families of proteins--the G-protein-coupled receptor kinases, which phosphorylate the agonist-occupied receptors, and the arrestin proteins, which subsequently bind to the receptors. We now present evidence that a group of proteins--the G0S8/Sst2p family--may be a third class of receptor-desensitizing factors.


Gene | 1998

Cloning of a retinally abundant regulator of G-protein signaling (RGS-r/RGS16): genomic structure and chromosomal localization of the human gene.

Bryan E. Snow; Laarni Antonio; Sid Suggs; David P. Siderovski

Regulators of G-protein signaling (RGS) constitute a family of GTPase-activating proteins with varying tissue-specific expression patterns and G-protein alpha subunit specificities. Here, we describe the molecular cloning of the human RGS-r/RGS16 cDNA, encoding a predicted polypeptide of 23kDa that shows 86% identity to mouse RGS-r. Northern blot analysis shows that, like the mouse Rgs-r message, hRGS-r mRNA is abundantly expressed in retina, with lower levels of expression in most other tissues examined. Characterization of the genomic organization of the hRGS-r gene shows that it consists of five exons and four introns. We have also mapped the human RGS-r /RGS16 gene to chromosome 1q25-1q31 by fluorescence in situ hybridzation. Analysis of human ESTs reveals that at least five members of the RGS gene family map to chromosome 1q, suggesting that at least part of the RGS family arose through gene duplication. The chromosomal location, retinal abundance, and presumed function of the human RGS-r protein in desensitizing photoreceptor signaling make the RGS-r/RGS16 locus a candidate for mutations responsible for retinitis pigmentosa with para-arteriolar preservation of retinal pigment epithelium (RP-PPRE or RP12), an autosomal recessive disorder previously mapped to 1q31.


Genes & Development | 1997

5′-Capping enzymes are targeted to pre-mRNA by binding to the phosphorylated carboxy-terminal domain of RNA polymerase II

Susan McCracken; Nova Fong; Emanuel Rosonina; Krassimir Yankulov; David P. Siderovski; Andrew Hessel; Stephen Foster; Amgen Est Program; Stewart Shuman; David L. Bentley


The Journal of Neuroscience | 1998

Dynamic Regulation of RGS2 Suggests a Novel Mechanism in G-Protein Signaling and Neuronal Plasticity

Tatsuya Ingi; Andrejs M. Krumins; Peter Chidiac; Sooyoung Chung; Bryan E. Snow; Carol A. Barnes; Anthony Lanahan; David P. Siderovski; Elliott M. Ross; Alfred G. Gilman; Paul F. Worley


Proceedings of the National Academy of Sciences of the United States of America | 1998

A G protein γ subunit-like domain shared between RGS11 and other RGS proteins specifies binding to Gβ5 subunits

Bryan E. Snow; Andrejs M. Krumins; Sheu-Fen Lee; Mark A. Wall; Stephen Chung; Joan Mangion; Sudha Arya; Alfred G. Gilman; David P. Siderovski


Nucleic Acids Research | 1995

Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE)

Toshifumi Matsuyama; Alex Grossman; Hans-Willi Mittrücker; David P. Siderovski; Friedemann Kiefer; Takatoshi Kawakami; Christopher D. Richardson; Tadatsugu Taniguchi; Steven Kiyoshi Yoshinaga; Tak W. Mak


Virology | 1995

HIV-1 Tat Directly Interacts with the Interferon-Induced, Double-Stranded RNA-Dependent Kinase, PKR

Nigel McMILLAN; Rene F. Chun; David P. Siderovski; Julien Galabru; W.Mark Toone; Charles E. Samuel; Tak W. Mak; Ara G. Hovanessian; Kuan-Teh Jeang; Bryan R. G. Williams


Biochemical and Biophysical Research Communications | 1997

Molecular cloning and expression analysis of rat Rgs12 and Rgs14

Bryan E. Snow; Laarni Antonio; Sid Suggs; Howard B. Gutstein; David P. Siderovski

Collaboration


Dive into the David P. Siderovski's collaboration.

Top Co-Authors

Avatar

Tak W. Mak

University Health Network

View shared research outputs
Top Co-Authors

Avatar

Bryan E. Snow

University Health Network

View shared research outputs
Top Co-Authors

Avatar

Alex Grossman

Ontario Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Josef M. Penninger

Ontario Institute for Cancer Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge